scispace - formally typeset
F

Fabrice Lemaître

Researcher at Pasteur Institute

Publications -  57
Citations -  3738

Fabrice Lemaître is an academic researcher from Pasteur Institute. The author has contributed to research in topics: Cytotoxic T cell & T cell. The author has an hindex of 29, co-authored 54 publications receiving 3263 citations. Previous affiliations of Fabrice Lemaître include French Institute of Health and Medical Research.

Papers
More filters
Journal ArticleDOI

Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells.

TL;DR: It is found that CD4+CD25high T cells are overrepresented in metastatic lymph nodes (LNs) with a 2-fold increased frequency compared with both tumor-free LNs and autologous PBMCs, which could explain the poor clinical response of cancer patients under immunotherapeutic protocols.
Journal ArticleDOI

Two-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice

TL;DR: Real-time imaging of tumor cell apoptosis in vivo using intravital 2-photon microscopy and a Förster resonance energy transfer-based (FRET-based) reporter of caspase 3 activity offers new perspectives for understanding how immune effectors survey cancer cells and how local tumor microenvironments may subvert immune responses.
Journal ArticleDOI

Real-Time Manipulation of T Cell-Dendritic Cell Interactions In Vivo Reveals the Importance of Prolonged Contacts for CD4+ T Cell Activation

TL;DR: The results establish the importance of prolonged T cell-DC interactions for efficient CD4(+) T cell activation in vivo and suggest that antigen availability on DCs regulates contact duration.
Journal ArticleDOI

Enumeration of human antigen–specific naive CD8+ T cells reveals conserved precursor frequencies

TL;DR: Development of a procedure for direct assessment of T-cell precursor frequency in humans has important implications, with particular relevance to vaccine development and monitoring of tumor and self-reactive T cells.